NexgenRX Inc. (NXG) — Cash Flow Quality Index
Latest as of September 2025:
1.49x
NexgenRX Inc. (NXG) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of CA$880.82K exceeds net income of CA$589.78K, indicating high earnings quality where cash backs reported profits. Explore NexgenRX Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.49x
Operating CF / Net Income
Operating Cash Flow
CA$880.82K
CAD
Net Income
CA$589.78K
CAD
Data as of
Sep 2025
Most recent filing
NexgenRX Inc. Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for NexgenRX Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does NexgenRX Inc. generate cash.
Annual Cash Flow Quality Index for NexgenRX Inc. (2013–2024)
Year-by-year earnings quality comparison for NexgenRX Inc..
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.87x | CA$1.15 Million | CA$614.57K | ▲ +96.6% |
| 2021 | 0.95x | CA$3.82 Million | CA$4.02 Million | ▼ -24.1% |
| 2020 | 1.25x | CA$2.65 Million | CA$2.12 Million | ▲ +50.1% |
| 2016 | 0.84x | CA$490.96K | CA$587.80K | ▼ -34.3% |
| 2013 | 1.27x | CA$774.08K | CA$608.55K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.